Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain...

Por Hasturk, Askin Esen, Gokce, Emre Cemal, Yilmaz, Erdal Resit, Horasanli, Bahriye, Evirgen, Oya, Hayirli, Nazli, Gokturk, Hilal, Erguder, Imge, Can, Belgin
Publicado no Asian J Neurosurg (2018)

A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor

Por Wang, Jiawan, Yao, Zhan, Jonsson, Philip, Allen, Amy N., Qin, Alice Can Ran, Uddin, Sharmeen, Dunkel, Ira J., Petriccione, Mary, Manova, Katia, Haque, Sofia, Rosenblum, Marc K., Pisapia, David J., Rosen, Neal, Taylor, Barry S., Pratilas, Christine A.
Publicado no Cancer Discov (2018)

Discovery of small molecule inhibitors of the HSP90-calcineurin-NFAT pathway against glioblastoma

Por Liu, Zhenzhen, Li, Hongli, He, Lian, Xiang, Yu, Tian, Chengsen, Li, Can, Tan, Peng, Jing, Ji, Tian, Yanpin, Du, Lupei, Huang, Yun, Han, Leng, Li, Minyong, Zhou, Yubin
Publicado no Cell Chem Biol (2019)

Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors

Por Curtin, James F., King, Gwendalyn D., Candolfi, Marianela, Greeno, Remy B., Kroeger, Kurt M., Lowenstein, Pedro R., Castro, Maria G.
Publicado em 2005

Significant tumor shift in patients treated with stereotactic radiosurgery for brain metastasis

Por Hessen, Eline D., van Buuren, Laurens D., Nijkamp, Jasper A., de Vries, Kim C., Kong Mok, Wai, Dewit, Luc, van Mourik, Anke M., Berlin, Alejandro, van der Heide, Uulke A., Borst, Gerben R.
Publicado no Clin Transl Radiat Oncol (2017)

Quality of Life Outcomes in Proton and Photon Treated Pediatric Brain Tumor Survivors

Por Yock, Torunn I., Bhat, Sundeep, Szymonifka, Jackie, Yeap, Beow Y., Delahaye, Jennifer, Donaldson, Sarah S., MacDonald, Shannon M., Pulsifer, Margaret B., Hill, Kristen S., DeLaney, Thomas F., Ebb, David, Huang, Mary, Tarbell, Nancy J., Fisher, Paul Graham, Kuhlthau, Karen A.
Publicado no Radiother Oncol (2014)

RDNA-17. POWER DENSITY LOSS CAN BE USED TO DEFINED TUMOR TREATING FIELDS DOSE

Por Hershkovich, Hadas, Urman, Noa, Naveh, Ariel, Levi, Shay, Bomzon, Zeev
Publicado no Neuro Oncol (2018)

The effectiveness of interventions to treat obesity in survivors of childhood brain tumors: a systematic review protocol

Por Wang, Kuan-Wen, Valencia, Marlie, Banfield, Laura, Chau, Ruth, Fleming, Adam, Singh, Sheila K., Burrow, Sarah, de Souza, Russell J., Thabane, Lehana, Samaan, M. Constantine
Publicado no Syst Rev (2016)

Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors

Por Mirlohi, Susan, Duncan, Susan E., Harmon, Michele, Case, Doug, Lesser, Glenn, Dietrich, Andrea M.
Publicado em 2014

EXTH-41. EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) ON BLOOD BRAIN BARRIER (BBB) PERMEABILITY

Por Kessler, Almuth, Schaeffer, Clara, Burek, Malgorzata, Ruschig, Ursula, Brami, Catherine Tempel, Voloshin, Tali, Giladi, Moshe, Ernestus, Rolf-Ingo, Löhr, Mario, Förster, Carola, Hagemann, Carsten
Publicado no Neuro Oncol (2018)

Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical note

Por Sandberg, David I., Kerr, Marcia L.
Publicado no Childs Nerv Syst (2015)

Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume for Stereotactic Radiosurgery-Treated Brain Metastasis Patients

Por Hirshman, Brian R, Wilson, Bayard, Ali, Mir Amaan, Proudfoot, James A, Koiso, Takao, Nagano, Osamu, Carter, Bob S, Serizawa, Toru, Yamamoto, Masaaki, Chen, Clark C
Publicado no Neurosurgery (2018)

QOL-34. A FOUR-YEAR FOLLOW-UP STUDY OF NEUROCOGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR

Por Lemiere, Jurgen, Vandereydt, Josefien, Van den Wyngaert, Linde, Vercruysse, Trui, Sleurs, Charlotte, Jacobs, Sandra
Publicado no Neuro Oncol (2018)

Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence

Por Johnson, Laura A, Sanchez-Perez, Luis, Suryadevara, Carter M, Sampson, John H
Publicado no Oncoimmunology (2014)

Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) Nanoparticles for Enhanced and Sustained Drug Delivery to Treat Brain Tumors

Por Chen, Evan M., Quijano, Amanda R., Seo, Young-Eun, Jackson, Christopher, Josowitz, Alexander D., Noorbakhsh, Seth, Merlettini, Andrea, Sundaram, Ranjini K., Focarete, Maria Letizia, Jiang, Zhaozhong, Bindra, Ranjit S., Saltzman, W. Mark
Publicado no Biomaterials (2018)

Tumors of the central nervous system brain tumors (part 1) /

Por Hayat, M. A.
Publicado em c201

Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: design of a randomized controlled double-blind trial

Por de Ruiter, Marieke A, Meeteren, Antoinette YN Schouten-Van, van Mourik, Rosa, Janssen, Tieme WP, Greidanus, Juliette EM, Oosterlaan, Jaap, Grootenhuis, Martha A
Publicado em 2012

Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study

Por Yuan, Hong, Zhang, Lei, Frank, Jonathan E., Inscoe, Christina R., Burk, Laurel M., Hadsell, Mike, Lee, Yueh Z., Lu, Jianping, Chang, Sha, Zhou, Otto
Publicado no Radiat Res (2015)

GENE-05. EVALUATION OF CLINICAL AND MOLECULAR FEATURES IN INFANTS AGED LESS THAN 12 MONTHS TREATED FOR AGGRESSIVE BRAIN TUMORS

Por Facchini, Ludovica, Guidi, Milena, Lucchesi, Maurizio, Buccoliero, Anna Maria, Giunti, Laura, Mocheo, Carla, Genitori, Lorenzo, Sardi, Iacopo
Publicado no Neuro Oncol (2017)

P01.048 A novel transducer array layout for delivering Tumor Treating Fields to the infratentorial brain at therapeutic levels

Por Bomzon, Z, Naveh, A, Levy, S, Kirson, E, Weinberg, U
Publicado no Neuro Oncol (2018)